MannKind Corp
MNKD
#4917
Rank
NZ$3.01 B
Marketcap
NZ$9.83
Share price
-0.53%
Change (1 day)
-14.06%
Change (1 year)

MannKind Corp (MNKD) - Cash on Hand

Cash on Hand as of September 2025 : NZ$0.45 Billion

According to MannKind Corp's latest financial reports the company has NZ$0.45 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

MannKind Corp - Cash on Hand chart (from 2004 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31NZ$0.34 B-25.05%
2023-12-31NZ$0.46 B73.41%
2022-12-31NZ$0.26 B-9.95%
2021-12-31NZ$0.29 B221.8%
2020-12-31NZ$92.86 M25.37%
2019-12-31NZ$74.06 M-30.18%
2018-12-31NZ$0.10 B71.44%
2017-12-31NZ$61.87 M87.21%
2016-12-31NZ$33.05 M-61.71%
2015-12-31NZ$86.31 M-44.04%
2014-12-31NZ$0.15 B79.04%
2013-12-31NZ$86.14 M14.6%
2012-12-31NZ$75.17 M2088.33%
2011-12-31NZ$3.43 M-96.24%
2010-12-31NZ$91.29 M104.06%
2009-12-31NZ$44.73 M-44.16%
2008-12-31NZ$80.11 M-83.34%
2007-12-31NZ$0.48 B-22.4%
2006-12-31NZ$0.61 B190.78%
2005-12-31NZ$0.21 B67.94%
2004-12-31NZ$0.12 B47.42%
2003-12-31NZ$86.06 M45.05%
2002-12-31NZ$59.33 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Halozyme Therapeutics
HALO
NZ$1.21 B 169.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
NZ$8.86 B 1,870.31%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Merck
MRK
NZ$31.52 B 6,904.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$17.16 B 3,712.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
NZ$0.46 B 3.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$25.93 B 5,662.30%๐Ÿ‡บ๐Ÿ‡ธ USA